MADRID, 19 Jun. (EUROPA PRESS) –
The pharmaceutical company Roche has launched ‘Dialogues PHC’, a cycle of virtual meetings to promote debate and dissemination around the development of personalized medicine, which aims to provide the appropriate treatment to each specific patient at the right time on the basis of the latest diagnostic and pharmacological advances and the analysis of clinical data.
Although personalized medicine is already a reality in some areas of the health systems and in certain pathologies, such as certain types of cancer, experts point out that it is necessary to develop different factors so that this medicine of the future becomes a reality as soon as possible. in the healthcare system.
In this sense, the use of precision diagnosis using genomic sequencing tools, which in the case of cancer allows defining the molecular profile of each tumor; the promotion of telemedicine and eHealth mobile applications; The enhancement of biomedical big data and the integration of artificial intelligence are some of these keys, as highlighted by participants on Thursday in the virtual meeting ‘PHC Dialogues: Present and future challenges’, organized by Roche.
“In the field of digital health and personalized medicine we have seen important advances in recent years, but nothing compared to the innovations that are already coming, and that will multiply in the coming years. I am talking about portable devices or ‘wereables’ that the patient will carry and they will allow the clinician to extract important data in real time to follow up much more precisely, from virtual assistants, to an electronic medical record model that can take advantage of the latest advances in artificial intelligence, and even drones for “, explained Jaime del Barrio, president of the Digital Health Association, senior advisor of Healthcare & Life Sciences at Ernst & Young and former director of the Roche Institute Foundation.
Del Barrio sees a healthcare of the future in which the advancement of digitization will avoid mistakes and oversights in taking medication and duplication of vaccination, and where face-to-face assistance will be reduced thanks to greater control through ‘eHealth’ devices, achieving a much more efficient healthcare model, saving resources and time for the benefit of professionals and patients.
–
